Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 12.10
-2.45 (-16.84%)
Apr 24, 2026, 1:55 PM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 377.26 million as of April 24, 2026. Its market cap has increased by 9.65% in one year.
Market Cap
377.26M
Enterprise Value
411.30M
Revenue
159.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.10
Market Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 377.26M, a decrease of -58.02%. That is a compound annual growth rate of -6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 377.26M | 28.87% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.03B |
| TCI GENE | 1.02B |
| NatureWise Biotech & Medicals | 916.55M |
| Neith | 793.51M |
| BioLASCO Taiwan | 759.40M |
| SynCore Biotechnology Co.,Ltd | 687.47M |
| Vectorite Biomedical | 652.19M |
| TaiwanJ Pharmaceuticals | 640.98M |